FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia
Leukemia, Published online: 09 September 2023; doi:10.1038/s41375-023-02020-wFBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - September 9, 2023 Category: Hematology Authors: Kasidy K. Dobish Karli J. Wittorf Samantha A. Swenson Dalton C. Bean Catherine M. Gavile Nicholas T. Woods Gargi Ghosal R. Katherine Hyde Shannon M. Buckley Source Type: research
Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank
Leukemia, Published online: 09 September 2023; doi:10.1038/s41375-023-02023-7Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank (Source: Leukemia)
Source: Leukemia - September 9, 2023 Category: Hematology Authors: Caitlyn Vlasschaert Elvis Akwo Cassianne Robinson-Cohen Elina K. Cook Matthew B. Lanktree Michael J. Rauh Alexander G. Bick Source Type: research
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European leukemia net risk classification
Leukemia, Published online: 07 September 2023; doi:10.1038/s41375-023-02016-6Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European leukemia net risk classification (Source: Leukemia)
Source: Leukemia - September 7, 2023 Category: Hematology Authors: Jan-Niklas Eckardt Marius Bill Christian Rausch Klaus Metzeler Karsten Spiekermann Sebastian Stasik Tim Sauer Sebastian Scholl Andreas Hochhaus Martina Crysandt Tim H. Br ümmendorf Utz Krug Bernhard W örmann Wolfgang Hiddemann Dennis G örlich Cristina Source Type: research
BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis
Leukemia, Published online: 06 September 2023; doi:10.1038/s41375-023-02019-3BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis (Source: Leukemia)
Source: Leukemia - September 6, 2023 Category: Hematology Authors: Tommaso Sconocchia Johannes Fo ßelteder Lisa Auinger Erdem Özkaya Theresa Benezeder Magdalena Lang Christine Beham-Schmid Gerald Hoefler Armin Zebisch Albert W ölfler Heinz Sill Peter Wolf Herbert Strobl Andreas Reinisch Source Type: research
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS
Leukemia, Published online: 06 September 2023; doi:10.1038/s41375-023-02015-7CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS (Source: Leukemia)
Source: Leukemia - September 6, 2023 Category: Hematology Authors: Karin Bauer Sigrid Machherndl-Spandl Lukas Kazianka Irina Sadovnik Sinan G ültekin Susanne Suessner Johannes Proell Jeroen Lauf Gregor Hoermann Gregor Eisenwort Norman H äfner Mathilde F ödermayr-Mayrleitner Ann-Sofie Schmolke Emiel van der Kouwe Uwe P Source Type: research
MiR-9-1 controls osteoblastic regulation of lymphopoiesis
Leukemia, Published online: 05 September 2023; doi:10.1038/s41375-023-02014-8MiR-9-1 controls osteoblastic regulation of lymphopoiesis (Source: Leukemia)
Source: Leukemia - September 5, 2023 Category: Hematology Authors: Yongguang Zhang Danfeng Lin Yongwei Zheng Yuhong Chen Mei Yu Dongya Cui Miaohui Huang Xinlin Su Yong Sun Yabing Chen Zhijian Qian Karen-Sue Carlson Renren Wen Demin Wang Source Type: research
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
Leukemia, Published online: 04 September 2023; doi:10.1038/s41375-023-01978-xCorrection: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes (Source: Leukemia)
Source: Leukemia - September 4, 2023 Category: Hematology Authors: Sonja I. Berndt Joseph Vijai Yolanda Benavente Nicola J. Camp Alexandra Nieters Zhaoming Wang Karin E. Smedby Geffen Kleinstern Henrik Hjalgrim Caroline Besson Christine F. Skibola Lindsay M. Morton Angela R. Brooks-Wilson Lauren R. Teras Charles Breeze J Source Type: research
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma
Leukemia, Published online: 30 August 2023; doi:10.1038/s41375-023-02013-9Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma (Source: Leukemia)
Source: Leukemia - August 30, 2023 Category: Hematology Authors: Franziska Briest Daniel Noerenberg Cornelius Hennch Kenichi Yoshida Raphael Hablesreiter Jose Nimo Daniel Sasca Marieluise Kirchner Larry Mansouri Yoshikage Inoue Laura Wiegand Annette M. Staiger Beatrice Casadei Penelope Korkolopoulou January Weiner Arma Source Type: research
Correction: Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?
Leukemia, Published online: 30 August 2023; doi:10.1038/s41375-023-02012-wCorrection: Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery? (Source: Leukemia)
Source: Leukemia - August 30, 2023 Category: Hematology Authors: Junren Chen Robert Peter Gale Yahui Feng Yu Hu Saibing Qi Xueou Liu Huaiping Zhu Xiaowen Gong Wei Zhang Huilan Liu Zimin Sun Source Type: research
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease
Leukemia, Published online: 28 August 2023; doi:10.1038/s41375-023-02009-5miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease (Source: Leukemia)
Source: Leukemia - August 28, 2023 Category: Hematology Authors: Carolina Caserta Silvia Nucera Matteo Barcella Grazia Fazio Matteo Maria Naldini Riccardo Pagani Francesca Pavesi Giacomo Desantis Erika Zonari Mariella D ’Angiò Paola Capasso Angelo Lombardo Ivan Merelli Orietta Spinelli Alessandro Rambaldi Fabio Cice Source Type: research
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL
Leukemia, Published online: 26 August 2023; doi:10.1038/s41375-023-02010-yPreclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Source: Leukemia)
Source: Leukemia - August 26, 2023 Category: Hematology Authors: Ze Tian Chunhua Shi Guojun Yang Jason K. Allen Qing Shi Amin AI-Shami Jill Wardell Olson Melinda G. Smith Qing Chang Jasbir Kaur Junping You Timothy E. Lofton Michelle A. Gonzalez Qi Zhang DongXing Zha Sarah K. Tasian Nitin Jain Marina Y. Konopleva Timoth Source Type: research
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets
Leukemia, Published online: 26 August 2023; doi:10.1038/s41375-023-02003-xGenomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets (Source: Leukemia)
Source: Leukemia - August 26, 2023 Category: Hematology Authors: Minako Mori Yasuo Kubota Arda Durmaz Carmelo Gurnari Charnise Goodings Vera Adema Ben Ponvilawan Waled S. Bahaj Tariq Kewan Thomas LaFramboise Manja Meggendorfer Claudia Haferlach John Barnard Marcin Wlodarski Valeria Visconte Torsten Haferlach Jaroslaw P Source Type: research
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
Leukemia, Published online: 26 August 2023; doi:10.1038/s41375-023-02008-6Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment (Source: Leukemia)
Source: Leukemia - August 26, 2023 Category: Hematology Authors: Heinz Gisslinger Christoph Klade Pencho Georgiev Dorota Krochmalczyk Liana Gercheva-Kyuchukova Miklos Egyed Petr Dulicek Arpad Illes Halyna Pylypenko Lylia Sivcheva Ji ří Mayer Vera Yablokova Kurt Krejcy Victoria Empson Hans C. Hasselbalch Robert Kralov Source Type: research
Who wins the combat, CAR or TCR?
Leukemia, Published online: 25 August 2023; doi:10.1038/s41375-023-01976-zWho wins the combat, CAR or TCR? (Source: Leukemia)
Source: Leukemia - August 25, 2023 Category: Hematology Authors: Kun Yun Elizabeth L. Siegler Saad S. Kenderian Source Type: research
How should we interpret conclusions of TKI-stopping studies
Leukemia, Published online: 25 August 2023; doi:10.1038/s41375-023-02002-yHow should we interpret conclusions of TKI-stopping studies (Source: Leukemia)
Source: Leukemia - August 25, 2023 Category: Hematology Authors: Robert Peter Gale Junren Chen Source Type: research
